According to Celldex Therapeutics's latest financial reports the company's current revenue (TTM ) is $7.02 Million USD. an increase over the revenue in the year 2023 that were of $6.88 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | $7.02 M | 1.99% |
2023 | $6.88 M | 192.02% |
2022 | $2.35 M | -49.33% |
2021 | $4.65 M | -37.28% |
2020 | $7.41 M | 107.58% |
2019 | $3.57 M | -62.53% |
2018 | $9.53 M | -25.17% |
2017 | $12.74 M | 87.81% |
2016 | $6.78 M | 23.79% |
2015 | $5.48 M | 52.84% |
2014 | $3.58 M | -12.77% |
2013 | $4.11 M | -63.3% |
2012 | $11.2 M | 20.91% |
2011 | $9.26 M | -80.2% |
2010 | $46.79 M | 208.25% |
2009 | $15.18 M | 103.61% |
2008 | $7.45 M | 171.9% |
2007 | $2.74 M | -44.39% |
2006 | $4.93 M | 59.67% |
2005 | $3.08 M | -54.97% |
2004 | $6.85 M | 48.04% |
2003 | $4.63 M | -30.9% |
2002 | $6.7 M | 100.39% |
2001 | $3.34 M | 338.42% |
2000 | $0.76 M | -46.68% |
1999 | $1.43 M | -34.94% |
1998 | $2.2 M | 69.23% |
1997 | $1.3 M | 8.33% |
1996 | $1.2 M |